A Study of TAK-881 and HyQvia in Healthy Adults
NCT: NCT06895967 · COMPLETED
Brief Summary
The main aim of this study is to understand how the body absorbs, processes, and removes (known as pharmacokinetics or PK) TAK-881 and HyQvia, after they are given as a single injection under the skin in healthy adults. Study participants will receive a single dose of TAK-881 or HyQvia on Day 1. During the study, participants will need to stay at the clinic for 8 days followed by 8 ambulatory follow up visits till Day 85.
Frequently Asked Questions
What is A Study of TAK-881 and HyQvia in Healthy Adults?
A Study of TAK-881 and HyQvia in Healthy Adults is a clinical trial registered under NCT06895967. Current status: COMPLETED.
What is the status of NCT06895967?
The current status of NCT06895967 (A Study of TAK-881 and HyQvia in Healthy Adults) is: COMPLETED.
When did A Study of TAK-881 and HyQvia in Healthy Adults start?
A Study of TAK-881 and HyQvia in Healthy Adults started on 2025-03-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.